Free, tracked US shipping over $199Third-party HPLC-MS testedPublished COA on every batchCold-chain protective packaging2–3 day US deliveryFor research use onlyFree, tracked US shipping over $199Third-party HPLC-MS testedPublished COA on every batchCold-chain protective packaging2–3 day US deliveryFor research use only
pepper.

Purity

99.87%

Method

HPLC-MS

Form

Lyophilized

Peptide BlendsE1Established clinical evidence

Tesamorelin / Ipamorelin

Stabilized GHRH analogue

99.87% HPLC-MSBatch PH-4235 In stock
$140per 15 mg vial

Vial strength

1
View purity report (COA)Ships in 1 business day

GHRH analogue that stimulates endogenous GH and increases IGF-1, reducing visceral adipose tissue in the labeled population.

Specifications

Compound class
Stabilized GHRH analogue
Sequence
Human GHRH(1-44) analogue with N-terminal trans-3-hexenoyl group
Chain length
44 aa
Physical form
Lyophilized powder
Modifications
N-terminal acyl modification improves resistance to degradation
Reported half-life
Product-label PK; short plasma persistence with downstream IGF-1 effect
Blend components
Tesamorelin · Ipamorelin
Verified purity
99.87% (HPLC-MS)
Evidence grade
E1 — Established clinical evidence
Read the full monograph in the Peptide Atlas

Research use only. All products sold on this website are intended for laboratory research and in-vitro experimentation only. They are not drugs, foods, cosmetics, or medical devices, and are not intended to diagnose, treat, cure, or prevent any disease. Nothing on this site should be construed as medical advice, dosing, or administration guidance. Purchasers must be qualified researchers or institutions and are solely responsible for lawful handling and use.

Related compounds